Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis

Respiratory Medicine

Volumn 105, Issue 1, 2011, Pages 106-113

  Korthagen, Nicoline M ^a   Van Moorsel, Coline H M ^a   Barlo, Nicole P ^a   Ruven, Henk J T ^a   Kruit, Adrian ^a   Heron, Michiel ^a   Van Den Bosch, Jules M M ^a,b   Grutters, Jan C ^a,b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

CHI3L1; Chitinase like proteins; Interstitial lung disease; Single nucleotide polymorphism; YKL 40

Indexed keywords

BIOLOGICAL MARKER; UNCLASSIFIED DRUG; YKL 40 PROTEIN;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; SURVIVAL;

ADIPOKINES; ADULT; AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GLYCOPROTEINS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LECTINS; MALE; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODELS;

EID: 78649945251     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.09.012     Document Type: Article

References (44)

1. B.D. Bringardner, C.P. Baran, T.D. Eubank, and C.B. Marsh The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis Antioxid Redox Signal 10 2 2008 Feb 287 301
2. T.M. Maher, A.U. Wells, and G.J. Laurent Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Eur Respir J 30 5 2007 Nov 835 839
3. S. Harari, and A.I.P.F. Caminati new insight on pathogenesis and treatment Allergy 65 5 2010 May 537 553
4. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive committee, June 2001 Respir Crit Care Med 165 2 2002 277 304
5. R.M. du Bois Strategies for treating idiopathic pulmonary fibrosis Nat Rev Drug Discov 9 2 2010 Feb 129 140
6. M. Demedts, J. Behr, R. Buhl, U. Costabel, R. Dekhuijzen, and H.M. Jansen High-dose acetylcysteine in idiopathic pulmonary fibrosis N Engl J Med 353 21 2005 Nov 24 2229 2242
7. J.S. Johansen, N.A. Schultz, and B.V. Jensen Plasma YKL-40: a potential new cancer biomarker? Future Oncol 5 7 2009 Sep 1065 1082
8. J.A. Elias, R.J. Homer, Q. Hamid, and C.G. Lee Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma J Allergy Clin Immunol 116 3 2005 Sep 497 500
9. A.D. Recklies, C. White, and H. Ling The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways Biochem J 365 Pt 1 2002 Jul 1 119 126
10. F. Badariotti, M. Kypriotou, C. Lelong, M.P. Dubos, E. Renard, and P. Galera The phylogenetically conserved molluscan chitinase-like protein 1 (Cg-Clp1), homologue of human HC-gp39, stimulates proliferation and regulates synthesis of extracellular matrix components of mammalian chondrocytes J Biol Chem 281 40 2006 Oct 6 29583 29596
11. H.F. Bigg, R. Wait, A.D. Rowan, and T.E. Cawston The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation J Biol Chem 281 30 2006 Jul 28 21082 21095
12. J.S. Johansen Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer Dan Med Bull 53 2 2006 May 172 209
13. I.E. Koutroubakis, E. Petinaki, P. Dimoulios, E. Vardas, M. Roussomoustakaki, and A.N. Maniatis Increased serum levels of YKL-40 in patients with inflammatory bowel disease Int J Colorectal Dis 18 3 2003 May 254 259 (Pubitemid 36764173)
14. K. Vos, P. Steenbakkers, A.M. Miltenburg, E. Bos, M.W. van Den Heuvel, and R.A. van Hogezand Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions Ann Rheum Dis 59 7 2000 Jul 544 548 (Pubitemid 30445834)
15. J.H. van Bilsen, D.H. van, L.R. Lard, V. van d, D.G. Elferink, and A.M. Bakker Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis Proc Natl Acad Sci USA 101 49 2004 Dec 7 17180 17185
16. K. Furuhashi, T. Suda, Y. Nakamura, N. Inui, D. Hashimoto, and S. Miwa Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis Respir Med 2010 Mar 26
17. Y. Erzin, H. Uzun, A. Karatas, and A.F. Celik Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease J Gastroenterol Hepatol 2007 Aug 27
18. J.S. Johansen, P. Christoffersen, S. Moller, P.A. Price, J.H. Henriksen, and C. Garbarsch Serum YKL-40 is increased in patients with hepatic fibrosis J Hepatol 32 6 2000 Jun 911 920
19. C. Nordenbaek, J.S. Johansen, P. Halberg, A. Wiik, C. Garbarsch, and S. Ullman High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement Scand J Rheumatol 34 4 2005 Jul 293 297
20. G.L. Chupp, C.G. Lee, N. Jarjour, Y.M. Shim, C.T. Holm, and S. He A chitinase-like protein in the lung and circulation of patients with severe asthma N Engl J Med 357 20 2007 Nov 15 2016 2027
21. A. Kruit, J.C. Grutters, H.J. Ruven, C.C. van Moorsel, and J.M. van den Bosch A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker Respir Med 101 7 2007 Jul 1563 1571
22. M.L. Berres, S. Papen, K. Pauels, P. Schmitz, M.M. Zaldivar, and C. Hellerbrand A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection J Hepatol 50 2 2009 Feb 370 376
23. C. Ober, Z. Tan, Y. Sun, J.D. Possick, L. Pan, and R. Nicolae Effect of variation in CHI3L1 on serum YKL-40 level, Risk of asthma, and lung function N Engl J Med 358 16 2008 Apr 9 1682 1691
24. M. Heron, W.A. Slieker, P. Zanen, E.G. van Lochem, H. Hooijkaas, and J.M. van den Bosch Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis Clin Immunol 126 3 2008 Mar 338 344
25. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2 2005 Jan 15 263 265
26. T.E. King Jr., J.A. Tooze, M.I. Schwarz, K.R. Brown, and R.M. Cherniack Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model Am J Respir Crit Care Med 164 7 2001 Oct 1 1171 1181
27. E.D. Manali, G.T. Stathopoulos, A. Kollintza, I. Kalomenidis, J.M. Emili, and C. Sotiropoulou The medical research council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis Respir Med 102 4 2008 Apr 586 592
28. C.A. Pereira, T. Malheiros, E.M. Coletta, R.G. Ferreira, A.S. Rubin, and J.S. Otta Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids Respir Med 100 2 2006 Feb 340 347
29. S.E. Gay, E.A. Kazerooni, G.B. Toews, J.P. Lynch III, B.H. Gross, and P.N. Cascade Idiopathic pulmonary fibrosis: predicting response to therapy and survival Am J Respir Crit Care Med 157 4 Pt 1 1998 Apr 1063 1072
30. D.A. Schwartz, R.A. Helmers, J.R. Galvin, D.S. Van Fossen, K.L. Frees, and C.S. Dayton Determinants of survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 149 2 Pt 1 1994 Feb 450 454
31. N. Barlo, C.H. van Moorsel, H.J. Ruven, P. Zanen, J.M. van den Bosch, and J.C. Grutters Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis Sarcoidosis Vasc Diffuse Lung Dis 26 2 2009 Oct 28 155 161
32. A. Prasse, C. Probst, E. Bargagli, G. Zissel, G.B. Toews, and K.R. Flaherty Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 179 8 2009 Apr 15 717 723
33. C.N. Rathcke, J. Holmkvist, T. Jorgensen, K. Borch-Johnsen, T. Hansen, and O.B. Pedersen Variation in CHI3LI in relation to type 2 diabetes and related quantitative traits PLoS ONE 4 5 2009 e5469
34. C.N. Rathcke, J. Holmkvist, L.L. Husmoen, T. Hansen, O. Pedersen, and H. Vestergaard Association of polymorphisms of the CHI3L1 gene with asthma and atopy: a populations-based study of 6514 Danish adults PLoS ONE 4 7 2009 e6106
35. M.H. Sohn, J.H. Lee, K.W. Kim, S.W. Kim, S.H. Lee, and K.E. Kim Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy Am J Respir Crit Care Med 179 6 2009 Mar 15 449 456
36. K. Ohi, R. Hashimoto, Y. Yasuda, T. Yoshida, H. Takahashi, and N. Iike The chitinase 3-like 1 gene and schizophrenia: evidence from a multi-center case-control study and meta-analysis Schizophr Res 116 2-3 2010 Feb 126 132
37. M. Ringsholt, E.V. Hogdall, J.S. Johansen, P.A. Price, and L.H. Christensen YKL-40 protein expression in normal adult human tissues-an immunohistochemical study J Mol Histol 38 1 2007 Mar 33 43
38. S.W. Krause, M. Rehli, M. Kreutz, L. Schwarzfischer, J.D. Paulauskis, and R. Andreesen Differential screening identifies genetic markers of monocyte to macrophage maturation J Leukoc Biol 60 4 1996 Oct 540 545
39. S. Letuve, A. Kozhich, N. Arouche, M. Grandsaigne, J. Reed, and M.C. Dombret YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages J Immunol 181 7 2008 Oct 1 5167 5173
40. B. Volck, P.A. Price, J.S. Johansen, O. Sorensen, T.L. Benfield, and H.J. Nielsen YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils Proc Assoc Am Physicians 110 4 1998 Jul 351 360
41. D. Baeten, A.M. Boots, P.G. Steenbakkers, D. Elewaut, E. Bos, and G.F. Verheijden Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis Arthritis Rheum 43 6 2000 Jun 1233 1243
42. S.R. Gilani, L.J. Vuga, K.O. Lindell, K.F. Gibson, J. Xue, and N. Kaminski CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis PLoS ONE 5 1 2010 e8959
43. C.N. Rathcke, and H. Vestergaard YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis Inflamm Res 55 6 2006 Jun 221 227
44. C.G. Lee, D. Hartl, G.R. Lee, B. Koller, H. Matsuura, and C.A. Da Silva Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis J Exp Med 206 5 2009 May 11 1149 1166